<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>6118041</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">30175041</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">6118041</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">S2213-1582(18)30266-3</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.1016/j.nicl.2018.08.025</article-id></all-ids><extracted-table><table-id>t0005</table-id><table-label>Table 1</table-label><table-caption>Symptom measures at baseline and post-training sessions.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="t0005" position="float"><label>Table 1</label><caption><p>Symptom measures at baseline and post-training sessions.</p></caption><alt-text id="al0025">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th colspan="3">Baseline<hr/></th><th colspan="3">Post-training<hr/></th></tr><tr><th>PTSD-exp</th><th>PTSD-ctrl</th><th>VC-exp</th><th>PTSD-exp</th><th>PTSD-ctrl</th><th>VC-exp</th></tr></thead><tbody><tr><td>CAPS (total)</td><td>51.7±16.7</td><td>59.2±21.0</td><td>2.6±2.6</td><td>38.2±19.8***</td><td>50.8±30.1</td><td>2.0±2.3</td></tr><tr><td>CAPS (sub-B)</td><td>9.9±6.9</td><td>15.2±7.1</td><td>0.0±0.0</td><td>7.5±6.1</td><td>11.2±10.3</td><td>0.2±0.6</td></tr><tr><td>CAPS (sub-C)</td><td>19.5±8.5</td><td>22.0±11.1</td><td>0.0±0.0</td><td>14.7±11.0**</td><td>17.6±18.1</td><td>0.8±1.7</td></tr><tr><td>CAPS (sub-D)</td><td>22.1±5.9</td><td>22.0±5.0</td><td>2.6±2.6</td><td>15.9±7.6**</td><td>22.0±6.0</td><td>1.0±2.2</td></tr><tr><td>PCL-M</td><td>42.2±10.6</td><td>49.3±16.8</td><td>19.8±3.0</td><td>36.0±12.8*</td><td>45.0±23.5</td><td>18.1±1.4</td></tr><tr><td>MADRS</td><td>19.8±8.7</td><td>15.3±13.2</td><td>1.8±2.1</td><td>12.8±8.4**</td><td>14.0±9.7</td><td>0.7±1.0</td></tr><tr><td>HAM-A</td><td>14.9±6.5</td><td>18.3±10.5</td><td>2.2±1.5</td><td>10.4±6.0**</td><td>14.5±6.7</td><td>1.1±1.4</td></tr></tbody></table><table-wrap-foot><fn><p>Means and standard deviations of symptom measures at the baseline and the post-training sessions. CAPS: Clinician-Administered PTSD Scale; CAPS (sub-B): CAPS Criterion B subscale, re-experiencing symptoms; CAPS (sub-C): CAPS Criterion C subscale, avoidance and numbing symptoms; CAPS (sub-D): CAPS Criterion D subscale, hyperarousal symptoms; PCL-M: MADRS: Montgomery-Åsberg Depression Scale; HAM-A: Hamilton Anxiety Rating Scale. * (<italic>p</italic> &lt; .05), ** (<italic>p</italic> &lt; .005), and *** (<italic>p</italic> &lt; .001) indicate significant (corrected <italic>p</italic>-values) symptom change between the baseline and the post-training sessions.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Symptom measures at baseline and post-training sessions.</div>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th colspan="3">Baseline</th><th colspan="3">Post-training</th></tr><tr><th>PTSD-exp</th><th>PTSD-ctrl</th><th>VC-exp</th><th>PTSD-exp</th><th>PTSD-ctrl</th><th>VC-exp</th></tr></thead><tbody><tr><td>CAPS (total)</td><td>51.7±16.7</td><td>59.2±21.0</td><td>2.6±2.6</td><td>38.2±19.8***</td><td>50.8±30.1</td><td>2.0±2.3</td></tr><tr><td>CAPS (sub-B)</td><td>9.9±6.9</td><td>15.2±7.1</td><td>0.0±0.0</td><td>7.5±6.1</td><td>11.2±10.3</td><td>0.2±0.6</td></tr><tr><td>CAPS (sub-C)</td><td>19.5±8.5</td><td>22.0±11.1</td><td>0.0±0.0</td><td>14.7±11.0**</td><td>17.6±18.1</td><td>0.8±1.7</td></tr><tr><td>CAPS (sub-D)</td><td>22.1±5.9</td><td>22.0±5.0</td><td>2.6±2.6</td><td>15.9±7.6**</td><td>22.0±6.0</td><td>1.0±2.2</td></tr><tr><td>PCL-M</td><td>42.2±10.6</td><td>49.3±16.8</td><td>19.8±3.0</td><td>36.0±12.8*</td><td>45.0±23.5</td><td>18.1±1.4</td></tr><tr><td>MADRS</td><td>19.8±8.7</td><td>15.3±13.2</td><td>1.8±2.1</td><td>12.8±8.4**</td><td>14.0±9.7</td><td>0.7±1.0</td></tr><tr><td>HAM-A</td><td>14.9±6.5</td><td>18.3±10.5</td><td>2.2±1.5</td><td>10.4±6.0**</td><td>14.5±6.7</td><td>1.1±1.4</td></tr></tbody></table></div>Means and standard deviations of symptom measures at the baseline and the post-training sessions. CAPS: Clinician-Administered PTSD Scale; CAPS (sub-B): CAPS Criterion B subscale, re-experiencing symptoms; CAPS (sub-C): CAPS Criterion C subscale, avoidance and numbing symptoms; CAPS (sub-D): CAPS Criterion D subscale, hyperarousal symptoms; PCL-M: MADRS: Montgomery-Åsberg Depression Scale; HAM-A: Hamilton Anxiety Rating Scale. * (p &lt; .05), ** (p &lt; .005), and *** (p &lt; .001) indicate significant (corrected p-values) symptom change between the baseline and the post-training sessions.</transformed-table></extracted-table></extracted-tables-set>